Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74


Regional Trends in Mortality from Alcohol-Induced Causes in the United States, 2000-2017.

Cholankeril G, Dennis BB, Kim D, Ahmed A.

J Gen Intern Med. 2019 Dec 2. doi: 10.1007/s11606-019-05442-4. [Epub ahead of print] No abstract available.


Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations.

Kovalic AJ, Cholankeril G, Satapathy SK.

Transl Gastroenterol Hepatol. 2019 Sep 3;4:65. doi: 10.21037/tgh.2019.08.09. eCollection 2019. Review.


Suboptimal Use of Inpatient Palliative Care Consultation May Lead to Higher Readmissions and Costs in End-Stage Liver Disease.

Adejumo AC, Kim D, Iqbal U, Yoo ER, Boursiquot BC, Cholankeril G, Wong RJ, Kwo PY, Ahmed A.

J Palliat Med. 2019 Aug 9. doi: 10.1089/jpm.2019.0100. [Epub ahead of print]


Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study.

Adejumo AC, Cholankeril G, Iqbal U, Yoo ER, Boursiquot BC, Concepcion WC, Kim D, Ahmed A.

Dig Dis Sci. 2019 Aug 1. doi: 10.1007/s10620-019-05759-4. [Epub ahead of print]


Depression is associated with non-alcoholic fatty liver disease among adults in the United States.

Kim D, Yoo ER, Li AA, Tighe SP, Cholankeril G, Harrison SA, Ahmed A.

Aliment Pharmacol Ther. 2019 Sep;50(5):590-598. doi: 10.1111/apt.15395. Epub 2019 Jul 22.


Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary.

Dibba P, Li AA, Cholankeril G, Ali Khan M, Kim D, Ahmed A.

Nutr Metab Insights. 2019 May 13;12:1178638819847480. doi: 10.1177/1178638819847480. eCollection 2019.


Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017.

Kim D, Adejumo AC, Yoo ER, Iqbal U, Li AA, Pham EA, Cholankeril G, Glenn JS, Ahmed A.

Gastroenterology. 2019 Oct;157(4):1055-1066.e11. doi: 10.1053/j.gastro.2019.06.026. Epub 2019 Jun 25.


Increasing Mortality Among Patients With Diabetes and Chronic Liver Disease From 2007 to 2017.

Kim D, Cholankeril G, Kim SH, Abbasi F, Knowles JW, Ahmed A.

Clin Gastroenterol Hepatol. 2019 Jun 17. pii: S1542-3565(19)30649-4. doi: 10.1016/j.cgh.2019.06.011. [Epub ahead of print]


Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation.

Cholankeril G, Li AA, Dennis BB, Gadiparthi C, Kim D, Toll AE, Maliakkal BJ, Satapathy SK, Nair S, Ahmed A.

Sci Rep. 2019 Jun 5;9(1):8312. doi: 10.1038/s41598-019-44814-y.


Hepatocellular carcinoma is leading in cancer-related disease burden among hospitalized baby boomers.

Gadiparthi C, Yoo ER, Are VS, Charilaou P, Kim D, Cholankeril G, Pitchumoni C, Ahmed A.

Ann Hepatol. 2019 Sep - Oct;18(5):679-684. doi: 10.1016/j.aohep.2019.04.014. Epub 2019 May 21.


Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014.

Kim D, Cholankeril G, Li AA, Kim W, Tighe SP, Hameed B, Kwo PY, Harrison SA, Younossi ZM, Ahmed A.

Liver Int. 2019 Sep;39(9):1661-1671. doi: 10.1111/liv.14135. Epub 2019 Jun 4.


Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017.

Kim D, Li AA, Cholankeril G, Kim SH, Ingelsson E, Knowles JW, Harrington RA, Ahmed A.

Diabetologia. 2019 Jul;62(7):1185-1194. doi: 10.1007/s00125-019-4870-9. Epub 2019 Apr 22.


Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States.

Kim D, Yoo ER, Li AA, Cholankeril G, Tighe SP, Kim W, Harrison SA, Ahmed A.

Liver Int. 2019 Jul;39(7):1335-1342. doi: 10.1111/liv.14110. Epub 2019 Apr 15.


The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD.

Perumpail BJ, Li AA, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A.

Diseases. 2019 Feb 25;7(1). pii: E27. doi: 10.3390/diseases7010027. Review.


Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016.

Kim D, Kim W, Adejumo AC, Cholankeril G, Tighe SP, Wong RJ, Gonzalez SA, Harrison SA, Younossi ZM, Ahmed A.

Hepatol Int. 2019 Mar;13(2):205-213. doi: 10.1007/s12072-018-09926-z. Epub 2019 Jan 29.


Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft.

Liu A, Galoosian A, Kaswala D, Li AA, Gadiparthi C, Cholankeril G, Kim D, Ahmed A.

J Clin Transl Hepatol. 2018 Dec 28;6(4):420-424. doi: 10.14218/JCTH.2018.00010. Epub 2018 Jul 28. Review.


Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis.

Iqbal U, Dennis BB, Li AA, Cholankeril G, Kim D, Khan MA, Ahmed A.

Hepatol Int. 2019 Jan;13(1):84-90. doi: 10.1007/s12072-018-9918-2. Epub 2018 Dec 12.


Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States.

Kim D, Yoo ER, Li AA, Fernandes CT, Tighe SP, Cholankeril G, Hameed B, Ahmed A.

Clin Gastroenterol Hepatol. 2019 Oct;17(11):2379-2381. doi: 10.1016/j.cgh.2018.11.024. Epub 2018 Nov 17.


Disparate Trends in Mortality of Etiology-Specific Chronic Liver Diseases Among Hispanic Subpopulations.

Kim D, Li AA, Perumpail RB, Cholankeril G, Gonzalez SA, Kim W, Ahmed A.

Clin Gastroenterol Hepatol. 2019 Jul;17(8):1607-1615.e2. doi: 10.1016/j.cgh.2018.10.045. Epub 2018 Nov 1.


Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic Steatohepatitis.

Molnar MZ, Joglekar K, Jiang Y, Cholankeril G, Abdul MKM, Kedia S, Gonzalez HC, Ahmed A, Singal A, Bhamidimarri KR, Aithal GP, Duseja A, Wong VW, Gulnare A, Puri P, Nair S, Eason JD, Satapathy SK; Global NAFLD Consortium.

Liver Transpl. 2019 Mar;25(3):399-410. doi: 10.1002/lt.25367.

Supplemental Content

Loading ...
Support Center